— Know what they know.
Not Investment Advice

BIEL OTC

Bioelectronics Corporation
1W: +0.0% 1M: +0.0% 3M: +20.0% YTD: -25.0% 1Y: +100.0% 3Y: -25.0% 5Y: -84.2%
$0.00
+0.00 (+0.00%)
 
Weekly Expected Move ±50.0%
$-0 $0 $0 $0 $0
OTC · Healthcare · Medical - Specialties · Tech Score Neutral · Power 49 · $7.4M mcap · 7.53B float · 0.137% daily turnover · Short 25% of daily vol

📊 Key Metrics

TTM
$1M
Revenue
-63.1% YoY
$-1M
Net Income
-479.9% YoY
$-0M
Free Cash Flow
-207.8% YoY
60.7%
Gross Margin
-61.8%
Op. Margin
-132.4%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE6.3%
ROA-388.9%
ROIC24.0%

Valuation

P/E-13.9
P/B-0.4
EV/EBITDA-53.4

Leverage

Debt/Equity-0.89
Current Ratio0.05
Interest Cov.-1.2x

Quality Scores

Piotroski F1/9
Altman Z-354.04
Beneish M-17.59

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms